Matthew Gline, CEO: Roivant Sciences ROIV Planned sale · Filed 04/16

Trade details

Type: Planned sale notice
Stock: Roivant Sciences ROIV
Person: Matthew GlineCEO
Planned sale date: 26/04/16
Filed: 26/04/16

More to sell after $9.9M in 3 months

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 03/17~05/16

Matthew Gline's recent trades

Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/20
Traded 04/16
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$12.3M
566,116 sh
$12.3M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$37.7M
1,740,000 sh
$37.7M
Filed 25/12/15
Traded 25/12/15